Barinthus Biotherapeutics PLC (BRNS)
2.21
-0.05
(-2.21%)
USD |
NASDAQ |
May 24, 16:00
2.13
-0.08
(-3.62%)
After-Hours: 20:00
Barinthus Biotherapeutics Price to Book Value: 0.502 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 24, 2024 | 0.502 |
May 23, 2024 | 0.5134 |
May 22, 2024 | 0.5225 |
May 21, 2024 | 0.4887 |
May 20, 2024 | 0.545 |
May 17, 2024 | 0.5338 |
May 16, 2024 | 0.552 |
May 15, 2024 | 0.5054 |
May 14, 2024 | 0.527 |
May 13, 2024 | 0.5327 |
May 10, 2024 | 0.5304 |
May 09, 2024 | 0.5338 |
May 08, 2024 | 0.5156 |
May 07, 2024 | 0.5154 |
May 06, 2024 | 0.5018 |
May 03, 2024 | 0.495 |
May 02, 2024 | 0.487 |
May 01, 2024 | 0.4995 |
April 30, 2024 | 0.4655 |
April 29, 2024 | 0.5881 |
April 26, 2024 | 0.5677 |
April 25, 2024 | 0.5515 |
April 24, 2024 | 0.5699 |
April 23, 2024 | 0.579 |
April 22, 2024 | 0.5949 |
Date | Value |
---|---|
April 19, 2024 | 0.5699 |
April 18, 2024 | 0.6153 |
April 17, 2024 | 0.5904 |
April 16, 2024 | 0.5745 |
April 15, 2024 | 0.5999 |
April 12, 2024 | 0.713 |
April 11, 2024 | 0.7561 |
April 10, 2024 | 0.7334 |
April 09, 2024 | 0.747 |
April 08, 2024 | 0.7357 |
April 05, 2024 | 0.7493 |
April 04, 2024 | 0.8333 |
April 03, 2024 | 0.6607 |
April 02, 2024 | 0.5381 |
April 01, 2024 | 0.5563 |
March 28, 2024 | 0.4959 |
March 27, 2024 | 0.4855 |
March 26, 2024 | 0.5001 |
March 25, 2024 | 0.5022 |
March 22, 2024 | 0.5376 |
March 21, 2024 | 0.5022 |
March 20, 2024 | 0.5105 |
March 19, 2024 | 0.5022 |
March 18, 2024 | 0.507 |
March 15, 2024 | 0.5156 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.298
Minimum
Sep 22 2023
2.310
Maximum
Jun 30 2021
0.8342
Average
0.6009
Median
Dec 05 2023
Price to Book Value Benchmarks
Achilles Therapeutics PLC | 0.2868 |
TC BioPharm (Holdings) PLC | 4.096 |
Adaptimmune Therapeutics PLC | 11.01 |
Biodexa Pharmaceuticals Plc | 0.9671 |
Verona Pharma PLC | 4.339 |
Price to Book Value Related Metrics
PS Ratio | 6.351 |
PEG Ratio | -0.0003 |
Price | 2.21 |
Earnings Yield | -83.26% |
Market Cap | 86.26M |
PEGY Ratio | -0.0003 |